IFNG and glioblastoma: Studies have shown that upregulation of the canonical interferon-gamma signaling pathway is associated with glioblastoma progression, and its expression in the tumor microenvironment significantly impacts overall survival in pediatric diffuse midline glioma (DMG) patients (47, 70–73).